Julie Bushman L.'s most recent trade in Phillips 66 was a trade of 1,423 Common Stock done at an average price of $140.6 . Disclosure was reported to the exchange on Jan. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phillips 66 | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 140.56 per share. | 15 Jan 2026 | 1,423 | 14,841 (0%) | 0% | 140.6 | 200,017 | Common Stock |
| Bio-Techne | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 1,640 | 8,775 (0%) | 0% | 0 | Common Stock | |
| Adient PLC | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 10,118 | 51,458 (0%) | 0% | - | Ordinary Shares | |
| Phillips 66 | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 118.78 per share. | 15 Jan 2025 | 1,684 | 12,921 (0%) | 0% | 118.8 | 200,020 | Common Stock |
| Bio-Techne | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 3,511 | 3,511 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 1,462 | 7,135 (0%) | 0% | 0 | Common Stock | |
| Adient PLC | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 4,207 | 41,340 (0%) | 0% | - | Ordinary Shares | |
| Phillips 66 | Julie Bushman L. | Director | Grant, award, or other acquisition of securities at price $ 131.31 per share. | 16 Jan 2024 | 1,524 | 10,879 (0%) | 0% | 131.3 | 200,116 | Common Stock |
| Adient PLC | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 3,312 | 37,133 (0%) | 0% | - | Ordinary Shares | |
| Phillips 66 | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 103.68 per share. | 17 Jan 2023 | 1,929 | 9,004 (0%) | 0% | 103.7 | 200,008 | Common Stock |
| Bio-Techne | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 865 | 865 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 338 | 1,012 (0%) | 0% | 0 | Common Stock | |
| Adient PLC | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 4,531 | 33,821 (0%) | 0% | - | Ordinary Shares | |
| Phillips 66 | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 87.57 per share. | 14 Jan 2022 | 2,284 | 6,795 (0%) | 0% | 87.6 | 200,010 | Common Stock |
| Bio-Techne | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 633 | 633 | - | - | Stock Option (right to buy) | |
| Bio-Techne | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 194 | 674 (0%) | 0% | 0 | Common Stock | |
| Adient PLC | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2021 | 3,553 | 29,290 (0%) | 0% | - | Ordinary Shares |